Bellevue Life Sciences Acquisition (BLACR) Competitors $0.12 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends BLACR vs. ABLLL, ASGI, AFJKR, ATMCR, ARBKL, ATLCL, ATCOL, RILYN, RILYG, and RILYZShould you be buying Bellevue Life Sciences Acquisition stock or one of its competitors? The main competitors of Bellevue Life Sciences Acquisition include Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL), Abrdn Global Infrastructure Income Fund (ASGI), Aimei Health Technology (AFJKR), AlphaTime Acquisition (ATMCR), Argo Blockchain plc 8.75% Senior Notes due 2026 (ARBKL), Atlanticus Holdings Co. 6.125% Senior Notes due 2026 (ATLCL), Atlas (ATCOL), B. Riley Financial, Inc. - 6.50 (RILYN), B. Riley Financial, Inc. 5.00% Senior Notes due 2026 (RILYG), and B. Riley Financial, Inc. 5.25% Senior Notes due 2028 (RILYZ). These companies are all part of the "-" industry. Bellevue Life Sciences Acquisition vs. Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 Abrdn Global Infrastructure Income Fund Aimei Health Technology AlphaTime Acquisition Argo Blockchain plc 8.75% Senior Notes due 2026 Atlanticus Holdings Co. 6.125% Senior Notes due 2026 Atlas B. Riley Financial, Inc. - 6.50 B. Riley Financial, Inc. 5.00% Senior Notes due 2026 B. Riley Financial, Inc. 5.25% Senior Notes due 2028 Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (NASDAQ:ABLLL) and Bellevue Life Sciences Acquisition (NASDAQ:BLACR) are both -- companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, community ranking, profitability, media sentiment, valuation and analyst recommendations. Do analysts rate ABLLL or BLACR? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ABellevue Life Sciences Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the media favor ABLLL or BLACR? In the previous week, Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 had 1 more articles in the media than Bellevue Life Sciences Acquisition. MarketBeat recorded 1 mentions for Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 and 0 mentions for Bellevue Life Sciences Acquisition. Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028's average media sentiment score of 1.00 beat Bellevue Life Sciences Acquisition's score of 0.00 indicating that Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 is being referred to more favorably in the media. Company Overall Sentiment Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 Positive Bellevue Life Sciences Acquisition Neutral Which has preferable valuation and earnings, ABLLL or BLACR? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028$95.38MN/AN/AN/AN/ABellevue Life Sciences AcquisitionN/AN/AN/AN/AN/A Does the MarketBeat Community prefer ABLLL or BLACR? Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 and Bellevue Life Sciences Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028N/AN/ABellevue Life Sciences AcquisitionN/AN/A Is ABLLL or BLACR more profitable? Company Net Margins Return on Equity Return on Assets Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028N/A N/A N/A Bellevue Life Sciences Acquisition N/A N/A N/A SummaryAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 beats Bellevue Life Sciences Acquisition on 3 of the 3 factors compared between the two stocks. Ad Investing Daily2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfast... go to work... But if you say these two sentences to your broker... you could collect as much as $1,250 on Friday... no matter where you live, whether you're working or already retired. It all has to do with a unique stock market secret that's worked 97% of the time for the past 8 years running.Click here. Get Bellevue Life Sciences Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for BLACR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLACR vs. The Competition Export to ExcelMetricBellevue Life Sciences Acquisition- Industry-- SectorNASDAQ ExchangeMarket CapN/A$1.43M$1.43M$8.51BDividend YieldN/A8.95%8.95%4.17%P/E RatioN/AN/AN/A12.89Price / SalesN/AN/AN/A89.91Price / CashN/AN/AN/A31.25Price / BookN/AN/AN/A4.56Net IncomeN/AN/AN/A$224.58M7 Day Performance-4.04%-0.85%-0.85%-0.84%1 Month PerformanceN/A0.68%0.68%2.96%1 Year Performance-19.28%3.60%3.60%25.23% Bellevue Life Sciences Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLACRBellevue Life Sciences AcquisitionN/A$0.12flatN/A-19.3%$0.00N/A0.002ABLLLAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028N/A$26.40flatN/AN/A$0.00$95.38M0.00N/APositive NewsASGIAbrdn Global Infrastructure Income FundN/A$19.64+0.2%N/A+19.5%$0.00$35.94M0.00N/APositive NewsAFJKRAimei Health TechnologyN/A$0.21flatN/AN/A$0.00N/A0.00N/AGap UpATMCRAlphaTime AcquisitionN/A$0.17-26.1%N/AN/A$0.00N/A0.002Gap DownARBKLArgo Blockchain plc 8.75% Senior Notes due 2026N/A$9.20-7.1%N/A+47.8%$0.00N/A0.0048Gap DownATLCLAtlanticus Holdings Co. 6.125% Senior Notes due 2026N/A$23.70+0.6%N/A+2.4%$0.00N/A0.00357Negative NewsATCOLAtlasN/A$25.01-0.6%N/A+6.3%$0.00N/A0.00N/APositive NewsRILYNB. Riley Financial, Inc. - 6.50N/A$13.50+0.2%N/A-46.2%$0.00N/A0.002,210Positive NewsRILYGB. Riley Financial, Inc. 5.00% Senior Notes due 2026N/A$12.80+1.2%N/A-45.7%$0.00N/A0.00574Gap DownHigh Trading VolumeRILYZB. Riley Financial, Inc. 5.25% Senior Notes due 2028N/A$11.30-1.3%N/A-46.2%$0.00N/A0.00574Positive NewsGap Up Related Companies and Tools Related Companies ABLLL Competitors ASGI Competitors AFJKR Competitors ATMCR Competitors ARBKL Competitors ATLCL Competitors ATCOL Competitors RILYN Competitors RILYG Competitors RILYZ Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BLACR) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellevue Life Sciences Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
